TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/20/24 17:06 | 8/16/24 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | O | EVP,CFO, | M.d | 31 | 12.96 | 0 | 2 | 20 | 14 | D | |||||||||||||||
3/12/24 20:46 | 3/10/24 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | MD | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 5 | 53 | 13 | D | ||||||||||||||
3/11/24 21:39 | 3/7/24 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | MD | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 12 | 11 | D | |||||||||||||||
8/18/23 16:37 | 8/16/23 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | MD | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 2 | 107 | 5 | D | ||||||||||||||
3/14/23 17:19 | 3/10/23 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | MD | O | EVP,CFO, | M.d | 30 | 6.52 | 0 | 5 | 3 | D | |||||||||||||||
8/18/22 17:02 | 8/16/22 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kelly James Patrick | MD | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 2 | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |